EP1801231 - METHOD OF SCREENING BAFF SUPPRESSOR OR INHIBITOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.10.2012 Database last updated on 19.10.2024 | Most recent event Tooltip | 18.07.2014 | Lapse of the patent in a contracting state New state(s): HU | published on 20.08.2014 [2014/34] | Applicant(s) | For all designated states Kowa Co., Ltd. 6-29, Nishiki 3-chome Naka-ku Nagoya-shi, Aichi 460-8625 / JP | For all designated states Takeuchi, Tsutomu 2-20-7, Akatsutsumi Setagaya-ku Tokyo 156-0044 / JP | For all designated states Tsuzaka, Kensei 3-9-10-736 Takaidohigashi Suginami-ku Tokyo 168-0072 / JP | For all designated states Yoshimoto, Keiko 1-67-2-303, Yamatocho Nakano-ku Tokyo 165-0034 / JP | [N/P] |
Former [2007/26] | For all designated states Kowa Co., Ltd. 6-29, Nishiki 3-chome Naka-ku Nagoya-shi, Aichi 460-8625 / JP | ||
For all designated states Takeuchi, Tsutomu 2-20-7, Akatsutsumi Setagaya-ku Tokyo 156-0044 / JP | |||
For all designated states Tsuzaka, Kensei 3-9-10-736 Takaidohigashi Suginami-ku Tokyo 168-0072 / JP | |||
For all designated states Yoshimoto, Keiko 3-6-1-3-M, Hikaricho Kokubunji-shi, Tokyo 185-0034 / JP | Inventor(s) | 01 /
TAKEUCHI, Tsutomu 2-20-7, Akatsutsumi Setagaya-ku Tokyo 156-0044 / JP | 02 /
TSUZAKA, Kensei 3-9-10-736, Takaidohigashi Suginami-ku Tokyo 1680072 / JP | 03 /
YOSHIMOTO, Keiko 3-6-1-3-M, Hikaricho Kokubunji-shi, Tokyo 185-0034 / JP | [2011/48] |
Former [2007/34] | 01 /
TAKEUCHI, Tsutomu 2-20-7, Akatsutsumi, Setagaya-ku Tokyo 156-0044 / JP | ||
02 /
TSUZAKA, Kensei 3-9-10-736, Takaidohigashi, Suginami-ku Tokyo 1680072 / JP | |||
03 /
YOSHIMOTO, Keiko 3-6-1-3-M, Hikaricho Kokubunji-shi, Tokyo 185-0034 / JP | |||
Former [2007/26] | 01 /
TAKEUCHI, Tsutomu 2-20-7, Akatsutsumi, Setagaya-ku Tokyo 156-0044 / JP | ||
02 /
TZUSAKA, Kensei 3-9-10-736, Takaidohigashi, Suginami-ku Tokyo 1680072 / JP | |||
03 /
YOSHIMOTO, Keiko 3-6-1-3-M, Hikaricho Kokubunji-shi, Tokyo 185-0034 / JP | Representative(s) | Hiebl, Inge Elisabeth Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
Former [2011/48] | Hiebl, Inge Elisabeth Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE | ||
Former [2007/26] | Hiebl, Inge Elisabeth Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 05783483.0 | 14.09.2005 | [2007/26] | WO2005JP16888 | Priority number, date | US20040609826P | 15.09.2004 Original published format: US 609826 P | [2007/26] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006030802 | Date: | 23.03.2006 | Language: | EN | [2006/12] | Type: | A1 Application with search report | No.: | EP1801231 | Date: | 27.06.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.2006 takes the place of the publication of the European patent application. | [2007/26] | Type: | B1 Patent specification | No.: | EP1801231 | Date: | 30.11.2011 | Language: | EN | [2011/48] | Search report(s) | International search report - published on: | JP | 23.03.2006 | (Supplementary) European search report - dispatched on: | EP | 23.04.2008 | Classification | IPC: | C12Q1/02, C12Q1/68, A61K39/395, A61K31/341, A61P43/00 | [2007/26] | CPC: |
C07K16/2875 (EP,US);
A61K31/341 (EP,US);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/02 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
G01N33/5008 (EP,US);
G01N33/5023 (EP,US);
G01N33/505 (EP,US);
G01N33/5052 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/26] | Title | German: | VERFAHREN ZUM SCREENING DES BAFF-SUPPRESSORS ODER -INHIBITORS | [2007/26] | English: | METHOD OF SCREENING BAFF SUPPRESSOR OR INHIBITOR | [2007/26] | French: | PROCÉDÉ DE RECHERCHE PAR SCRIBLAGE D'UN SUPPRESSEUR OU INHIBITEUR DU BAFF | [2007/26] | Entry into regional phase | 30.03.2007 | Translation filed | 30.03.2007 | National basic fee paid | 30.03.2007 | Search fee paid | 30.03.2007 | Designation fee(s) paid | 30.03.2007 | Examination fee paid | Examination procedure | 30.03.2007 | Examination requested [2007/26] | 25.06.2008 | Despatch of a communication from the examining division (Time limit: M06) | 22.12.2008 | Reply to a communication from the examining division | 03.11.2010 | Despatch of a communication from the examining division (Time limit: M04) | 07.03.2011 | Reply to a communication from the examining division | 01.08.2011 | Communication of intention to grant the patent | 18.10.2011 | Fee for grant paid | 18.10.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.06.2008 | Opposition(s) | 31.08.2012 | No opposition filed within time limit [2012/45] | Fees paid | Renewal fee | 12.09.2007 | Renewal fee patent year 03 | 15.09.2008 | Renewal fee patent year 04 | 08.09.2009 | Renewal fee patent year 05 | 10.09.2010 | Renewal fee patent year 06 | 27.09.2011 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 14.09.2005 | AT | 30.11.2011 | BE | 30.11.2011 | CY | 30.11.2011 | CZ | 30.11.2011 | DK | 30.11.2011 | EE | 30.11.2011 | FI | 30.11.2011 | LT | 30.11.2011 | LV | 30.11.2011 | NL | 30.11.2011 | PL | 30.11.2011 | RO | 30.11.2011 | SE | 30.11.2011 | SI | 30.11.2011 | SK | 30.11.2011 | TR | 30.11.2011 | BG | 29.02.2012 | GR | 01.03.2012 | ES | 11.03.2012 | IS | 30.03.2012 | PT | 30.03.2012 | [2014/34] |
Former [2014/21] | AT | 30.11.2011 | |
BE | 30.11.2011 | ||
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
FI | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
PL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
TR | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
ES | 11.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2013/29] | AT | 30.11.2011 | |
BE | 30.11.2011 | ||
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
FI | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
PL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
ES | 11.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2013/22] | AT | 30.11.2011 | |
BE | 30.11.2011 | ||
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
PL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
ES | 11.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2013/07] | AT | 30.11.2011 | |
BE | 30.11.2011 | ||
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
PL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/37] | BE | 30.11.2011 | |
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
PL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/36] | BE | 30.11.2011 | |
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
RO | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
SK | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/35] | BE | 30.11.2011 | |
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
DK | 30.11.2011 | ||
EE | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
BG | 29.02.2012 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/34] | BE | 30.11.2011 | |
CY | 30.11.2011 | ||
CZ | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/28] | BE | 30.11.2011 | |
CY | 30.11.2011 | ||
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/25] | BE | 30.11.2011 | |
LT | 30.11.2011 | ||
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/24] | LT | 30.11.2011 | |
LV | 30.11.2011 | ||
NL | 30.11.2011 | ||
SE | 30.11.2011 | ||
SI | 30.11.2011 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/23] | LT | 30.11.2011 | |
NL | 30.11.2011 | ||
GR | 01.03.2012 | ||
IS | 30.03.2012 | ||
PT | 30.03.2012 | ||
Former [2012/21] | LT | 30.11.2011 | |
IS | 30.03.2012 | ||
Former [2012/20] | LT | 30.11.2011 | Documents cited: | Search | [X] - MARIENFELD RALF ET AL, "Signal-specific and phosphorylation-dependent RelB degradation: A potential mechanism of NF-kappaB control", ONCOGENE, (20011206), vol. 20, no. 56, ISSN 0950-9232, pages 8142 - 8147, XP002475875 [X] 11-14 * p. 8142, col. 2, lines 13 - 20, fig. 1d and e, fig. 4b * DOI: http://dx.doi.org/10.1038/sj.onc.1204884 | [A] - LAVIE FRÉDÉRIC ET AL, "Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.", THE JOURNAL OF PATHOLOGY APR 2004, (200404), vol. 202, no. 4, ISSN 0022-3417, pages 496 - 502, XP002475876 [A] 1-14 * abstract * DOI: http://dx.doi.org/10.1002/path.1533 | [A] - SCHNEIDER P ET AL, "BAFF, A NOVEL LIGAND OF THE TUMOR NECROSIS FACTOR FAMILY, STIMULATES B CELL GROWTH", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, (19990607), vol. 189, no. 11, ISSN 0022-1007, pages 1747 - 1756, XP000915409 [A] 1-14 * abstract, p. 1752, paragraph bridging cols. 1and 2 * DOI: http://dx.doi.org/10.1084/jem.189.11.1747 | [T] - YOSHIMOTO KEIKO ET AL, "Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy", INTERNATIONAL IMMUNOLOGY, (200607), vol. 18, no. 7, ISSN 0953-8178, pages 1189 - 1196, XP002475877 [T] 1-14 DOI: http://dx.doi.org/10.1093/intimm/dxl053 | International search | [X] - SHU H.B. ET AL, "TALL-1 is a novel member of the TNF family that is down regulated by mitogens", JOURNAL OF LEUKOCYTE BIOLOGY, (1999), vol. 65, no. 5, pages 680 - 683, XP000939092 | [Y] - MOORE P.A. ET AL, "BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator", SCIENCE, (1999), vol. 285, no. 5425, pages 260 - 263, XP002142252 DOI: http://dx.doi.org/10.1126/science.285.5425.260 | [Y] - BEN-BASSAT H. ET AL, "Establishment of a human T-Acute Lymphoblastic leukemia Cell Line with a (16;20) Chromosome Translocation", CANCER GENET. CYTOGENET., (1990), vol. 49, no. 2, pages 241 - 248, XP002993867 DOI: http://dx.doi.org/10.1016/0165-4608(90)90148-4 | [Y] - HUARD B. ET AL, "BAFF production by antigen-presenting cells provides T cell co-stimulation", INT. IMMUNOL., (200403), vol. 16, no. 3, pages 467 - 475, XP002993868 DOI: http://dx.doi.org/10.1093/intimm/dxh043 | [Y] - KHARE S.D. ET AL, "Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice", PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, no. 7, pages 3370 - 3375, XP002142253 DOI: http://dx.doi.org/10.1073/pnas.050580697 | [A] - WU D. ET AL, "Expression of THANK in human PBMC activated with different stimulator", XIBAO YU FENZI MIANYIXUE ZAZHI, (2001), vol. 17, no. 4, pages 304 - 306, XP008058996 | by applicant | WO9818921 | - MOORE ET AL., SCIENCE, (1999), vol. 285, pages 260 - 263 | - HUARD B. ET AL., INT. IMMUNOL., (200403), vol. 16, no. 3, pages 467 - 475 | - MARIENFELD R. ET AL., ONCOGENE, (20011206), vol. 20, no. 56, pages 8142 - 8147 | - YOSHIMOTO K. ET AL., INT. IMMUNOL., (200607), vol. 18, no. 7, pages 1189 - 1196 | - SHU H. B. ET AL., J. LEUCOCYTE BIOL., (1999), vol. 65, no. 5, pages 680 - 683 |